Want to join the conversation?
$EMR remains focused on the completion of both the restructuring programs and strategic portfolio repositioning activities that were initiated in the prior year. $EMR's long-standing commitment to return cash flow to its shareholders will be supported by an expected increase in operating cash flow in FY16 to about $3Bil.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?